Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment.
Vinholes
J
J
YCRC Department of Clinical Oncology, Weston Park Hospital, University of Sheffield, UK.
Coleman
R
R
Eastell
R
R
D000469:Alkaline Phosphatase / Q000378:metabolism; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000378:metabolism; D001846:Bone Development / Q000502:physiology; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000556:secondary*; D001862:Bone Resorption / Q000188:drug therapy / Q000378:metabolism; D001842:Bone and Bones / Q000033:anatomy & histology / Q000378:metabolism*; D003432:Cross-Linking Reagents / Q000378:metabolism; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D009362:Neoplasm Metastasis / Q000503:physiopathology; D015675:Osteocalcin / Q000378:metabolism; D011726:Pyridinium Compounds / Q000378:metabolism; D011859:Radiography
D015415:Biomarkers; D014408:Biomarkers, Tumor; D003432:Cross-Linking Reagents; D004164:Diphosphonates; D011726:Pyridinium Compounds; D015675:Osteocalcin; D000469:Alkaline Phosphatase